Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Edelman

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Plos Neglected Tropical Diseases|October 5, 2018
Dengue illness index-A tool to characterize the subjective dengue illness experienceStephen J Thomas, Liane Agulto, Kim Hendrickx, et al.
Vaccine|November 27, 2002
Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoitesRobert Edelman, Steven S Wasserman, James G Kublin, et al.
Vaccine|July 7, 2009
Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adultsRebecca C Brady, John J Treanor, Robert L Atmar, et al.
The Journal of Infectious Diseases|July 10, 2004
Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT StudyThuan Le, James D Cherry, Swei-Ju Chang, et al.
Vaccine|October 5, 2007
Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjectsRobert B Couch, Patricia Winokur, Rebecca Brady, et al.
Immunity & Ageing : I & A|May 2, 2020
The SENIEUR protocol and the efficacy of hepatitis B vaccination in healthy elderly persons by age, gender, and vaccine routeRobert Edelman, Meagan E Deming, Franklin R Toapanta, et al.
Plos One|July 23, 2013
Successful human infection with P. falciparum using three aseptic Anopheles stephensi mosquitoes: a new model for controlled human malaria infectionMatthew B Laurens, Peter Billingsley, Adam Richman, et al.
The American Journal of Tropical Medicine and Hygiene|September 30, 2015
Optimizing Intradermal Administration of Cryopreserved Plasmodium falciparum Sporozoites in Controlled Human Malaria InfectionKirsten E Lyke, Matthew B Laurens, Kathy Strauss, et al.
The Journal of Infectious Diseases|October 16, 2008
Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individualsAnn R Falsey, Edward E Walsh, Jose Capellan, et al.
The Lancet. Infectious Diseases|April 28, 2024
Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trialKirsten E Lyke, Joel V Chua, Michael Koren, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Plos Neglected Tropical Diseases|October 5, 2018
Dengue illness index-A tool to characterize the subjective dengue illness experienceStephen J Thomas, Liane Agulto, Kim Hendrickx, et al.
Vaccine|November 27, 2002
Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoitesRobert Edelman, Steven S Wasserman, James G Kublin, et al.
Vaccine|July 7, 2009
Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adultsRebecca C Brady, John J Treanor, Robert L Atmar, et al.
The Journal of Infectious Diseases|July 10, 2004
Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT StudyThuan Le, James D Cherry, Swei-Ju Chang, et al.
Vaccine|October 5, 2007
Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjectsRobert B Couch, Patricia Winokur, Rebecca Brady, et al.
Immunity & Ageing : I & A|May 2, 2020
The SENIEUR protocol and the efficacy of hepatitis B vaccination in healthy elderly persons by age, gender, and vaccine routeRobert Edelman, Meagan E Deming, Franklin R Toapanta, et al.
Plos One|July 23, 2013
Successful human infection with P. falciparum using three aseptic Anopheles stephensi mosquitoes: a new model for controlled human malaria infectionMatthew B Laurens, Peter Billingsley, Adam Richman, et al.
The American Journal of Tropical Medicine and Hygiene|September 30, 2015
Optimizing Intradermal Administration of Cryopreserved Plasmodium falciparum Sporozoites in Controlled Human Malaria InfectionKirsten E Lyke, Matthew B Laurens, Kathy Strauss, et al.
The Journal of Infectious Diseases|October 16, 2008
Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individualsAnn R Falsey, Edward E Walsh, Jose Capellan, et al.
The Lancet. Infectious Diseases|April 28, 2024
Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trialKirsten E Lyke, Joel V Chua, Michael Koren, et al.
Pageof 6